A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn.

Mohamed, W A

A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn. [electronic resource] - Journal of perinatology : official journal of the California Perinatal Association Aug 2012 - 608-13 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1476-5543

10.1038/jp.2011.157 doi


Antihypertensive Agents--adverse effects
Bosentan
Double-Blind Method
Female
Humans
Hypertension, Pulmonary--drug therapy
Infant, Newborn
Male
Prospective Studies
Sulfonamides--adverse effects
Treatment Outcome